Mineralys Therapeutics, Inc.
MLYS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$36,932 | -$43,274 | -$42,211 | -$48,946 |
| Dep. & Amort. | $15 | $16 | $15 | $15 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $5,841 | $4,553 | $3,645 | $3,134 |
| Change in WC | $4,600 | $10,765 | -$5,890 | -$19,709 |
| Other Non-Cash | -$2,396 | -$2,229 | -$1,046 | -$1,337 |
| Operating Cash Flow | -$28,872 | -$30,169 | -$45,487 | -$66,843 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$300,507 | -$117,881 | -$127,876 | -$63,930 |
| Inv. Sales/Matur. | $150,000 | $75,000 | $35,000 | $147,500 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$150,507 | -$42,881 | -$92,876 | $83,570 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $288,593 | $9,831 | $189,166 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $6,595 | $0 | $113 | $90 |
| Financing Cash Flow | $295,188 | $9,831 | $189,279 | $90 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $115,809 | -$63,219 | $50,916 | $16,817 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $101,788 | $165,007 | $114,091 | $97,274 |
| End Cash | $217,597 | $101,788 | $165,007 | $114,091 |
| Free Cash Flow | -$28,872 | -$30,169 | -$45,487 | -$66,843 |